These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 18261318)

  • 1. [Reaching increased understanding of the gastrointestinal barrier requires a multidisciplinary effort].
    Hu FL
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(42):2953-4. PubMed ID: 18261318
    [No Abstract]   [Full Text] [Related]  

  • 2. Helicobacter pylori and nonsteroidal antiinflammatory drugs: partners in crime?
    Jones NL; Sherman P; Wang B; Inman RD
    Bull Rheum Dis; 1997 Dec; 46(8):6-8. PubMed ID: 9409058
    [No Abstract]   [Full Text] [Related]  

  • 3. Where have all the Helicobacters gone?
    Genta RM
    J Clin Gastroenterol; 2007 Sep; 41(8):727-8. PubMed ID: 17700419
    [No Abstract]   [Full Text] [Related]  

  • 4. Helicobacter pylori and NSAIDS--more questions than answers.
    Ryan MJ
    Am J Gastroenterol; 1991 Aug; 86(8):1090-1. PubMed ID: 1858749
    [No Abstract]   [Full Text] [Related]  

  • 5. [NSAID-induced damage to the gastrointestinal mucosa].
    Rodonezhskaia EV; Kharchenko NV
    Lik Sprava; 2001; (4):179-80. PubMed ID: 11692710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Helicobacter pylori--a model for colonization and survival in a hostile environment].
    Regev A; Strul H; Niv Y
    Harefuah; 1998 Feb; 134(4):301-4. PubMed ID: 10909511
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experimental model of infection of Helicobacter pylori in the mouse. A study of gastric damage caused by indomethacin].
    Schraier M; Petrelli L; Bonfanti M; Di Bella A; Pest P; Man F; Adami J; Tokumoto M
    Acta Gastroenterol Latinoam; 2001; 31(3):115-21. PubMed ID: 11577562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Endoscopic changes in the stomach and duodenal mucosa caused by microdose acetylsalicylic acid therapy and their prevention--editorial].
    Ehrmann J; Procházka V; Konecný M; Spacek M; Urbánek K
    Vnitr Lek; 2007 Oct; 53(10):1024-8. PubMed ID: 18072422
    [No Abstract]   [Full Text] [Related]  

  • 9. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.
    Wolfe MM; Lichtenstein DR; Singh G
    N Engl J Med; 1999 Jun; 340(24):1888-99. PubMed ID: 10369853
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of Sulforaphane in Protection of Gastrointestinal Tract Against H. pylori and NSAID-Induced Oxidative Stress.
    Yanaka A
    Curr Pharm Des; 2017; 23(27):4066-4075. PubMed ID: 28176666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NSAID disorders in the esophagus, stomach and duodenum have been an important topic for a long time. Foreword.
    Terano A
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():Siv. PubMed ID: 20586877
    [No Abstract]   [Full Text] [Related]  

  • 12. [The gastric mucosal barrier. Introduction].
    Lanas Arbeloa A
    Gastroenterol Hepatol; 1997 May; 20 Suppl 2():1-3. PubMed ID: 9254246
    [No Abstract]   [Full Text] [Related]  

  • 13. Irritation of gastrointestinal mucosa by new glycosyl derivative of diclofenac in comparison with diclofenac in rats.
    Borowiecka J; Pakulska W; Graczyk J; Wagrowska-Danilewicz M
    Acta Pol Pharm; 2000 Nov; 57 Suppl():99-102. PubMed ID: 11293281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helicobacter pylori and non-malignant diseases.
    Furuta T; Delchier JC
    Helicobacter; 2009 Sep; 14 Suppl 1():29-35. PubMed ID: 19712165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori and non-malignant diseases.
    Shirin H; Leja M; Niv Y
    Helicobacter; 2008 Oct; 13 Suppl 1():23-7. PubMed ID: 18783518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori eradication in patients on long-term treatment with NSAIDs reduces the severity of gastritis: a randomized controlled trial.
    De Leest HT; Steen KS; Bloemena E; Lems WF; Kuipers EJ; Van de Laar MA; Bijlsma JW; Janssen M; Houben HH; Kostense PJ; Boers M; Dijkmans BA
    J Clin Gastroenterol; 2009 Feb; 43(2):140-6. PubMed ID: 18797408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protecting the stomach from the "toxins" of NSAIDS and anti-platelet agents.
    Echelmeyer S; Kanwal F
    Mo Med; 2009; 106(5):343-5. PubMed ID: 19902714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-steroidal anti-inflammatory drugs request parity with Helicobacter pylori.
    Ladwa M; Takeuchi K; Bjarnason I
    Scand J Gastroenterol; 2006 Apr; 41(4):373-5. PubMed ID: 16635902
    [No Abstract]   [Full Text] [Related]  

  • 19. Helicobacter pylori eradication and gastric cancer: when is the horse out of the barn?
    de Vries AC; Kuipers EJ; Rauws EA
    Am J Gastroenterol; 2009 Jun; 104(6):1342-5. PubMed ID: 19491846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review article: non-steroidal anti-inflammatory drug-induced gastrointestinal permeability.
    Davies NM
    Aliment Pharmacol Ther; 1998 Apr; 12(4):303-20. PubMed ID: 9690719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.